$19.82
-0.42-2.08%
At close: -
$19.85
0.030.15%
After Hours: 7:16 PM EDT
Comments
Loading...
Beam Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:BEAM | Benzinga
Beam Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 20
EPS Estimate
$-1.170
Quarterly Revenue Estimate
$14.68M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$63.52M
Analyze the earnings history of Beam Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BEAM | Beam Therapeutics | -$1.11 | — | — | — | $11.77M | — | — | — | 08/05/2025 | Get Alert |
| BEAM | Beam Therapeutics | -$1.21 | -$1.17 | — | — | $7.41M | $14.68M | — | — | 05/20/2025 | Get Alert |
| BEAM | Beam Therapeutics | $1.73 | -$1.28 | -$1.09 | 14.84% | $316.19M | $15.12M | $30.07M | 98.86% | 02/25/2025 | Get Alert |
| BEAM | Beam Therapeutics | -$1.22 | -$1.16 | -$1.17 | -0.86% | $17.19M | $14.50M | $14.27M | -1.59% | 11/05/2024 | Get Alert |
| BEAM | Beam Therapeutics | -$1.08 | -$1.14 | -$1.11 | 2.63% | $20.12M | $13.73M | $11.77M | -14.26% | 08/06/2024 | Get Alert |
| BEAM | Beam Therapeutics | -$1.33 | -$1.42 | -$1.21 | 14.79% | $24.21M | $16.97M | $7.41M | -56.33% | 05/07/2024 | Get Alert |
| BEAM | Beam Therapeutics | -$0.54 | -$1.01 | $1.73 | 271.29% | $20.04M | $18.67M | $316.19M | 1593.58% | 02/27/2024 | Get Alert |
| BEAM | Beam Therapeutics | -$1.56 | -$1.34 | -$1.22 | 8.96% | $15.80M | $17.49M | $17.19M | -1.70% | 11/08/2023 | Get Alert |
| BEAM | Beam Therapeutics | -$1.02 | -$1.42 | -$1.08 | 23.94% | $16.65M | $18.05M | $20.12M | 11.45% | 08/08/2023 | Get Alert |
| BEAM | Beam Therapeutics | -$1.01 | -$1.34 | -$1.33 | 0.75% | $8.43M | $14.08M | $24.21M | 71.93% | 05/10/2023 | Get Alert |
| BEAM | Beam Therapeutics | -$0.95 | -$1.33 | -$0.54 | 59.40% | $51.07M | $12.53M | $20.04M | 59.91% | 02/28/2023 | Get Alert |
| BEAM | Beam Therapeutics | -$0.42 | -$1.31 | -$1.56 | -19.08% | $763.00K | $7.94M | $15.80M | 98.98% | 11/07/2022 | Get Alert |
| BEAM | Beam Therapeutics | -$1.23 | -$1.08 | -$1.02 | 5.56% | $6.00K | $8.39M | $16.65M | 98.47% | 08/09/2022 | Get Alert |
| BEAM | Beam Therapeutics | -$3.35 | -$1.32 | -$1.01 | 23.48% | $6.00K | $5.91M | $8.43M | 42.67% | 05/09/2022 | Get Alert |
| BEAM | Beam Therapeutics | -$1.69 | — | -$0.95 | — | $6.00K | — | $51.07M | — | 02/28/2022 | Get Alert |
| BEAM | Beam Therapeutics | -$0.69 | -$0.74 | -$0.42 | 43.24% | $6.00K | $7.19M | $763.00K | -89.39% | 11/08/2021 | Get Alert |
| BEAM | Beam Therapeutics | -$0.69 | -$0.65 | -$1.23 | -89.23% | $6.00K | — | $6.00K | — | 08/10/2021 | Get Alert |
| BEAM | Beam Therapeutics | -$1.03 | -$0.74 | -$3.35 | -352.70% | $6.00K | — | $6.00K | — | 05/11/2021 | Get Alert |
| BEAM | Beam Therapeutics | — | — | -$1.69 | — | — | — | $6.00K | — | 03/15/2021 | Get Alert |
| BEAM | Beam Therapeutics | -$3.31 | — | -$0.69 | — | — | — | $6.00K | — | 11/10/2020 | Get Alert |
| BEAM | Beam Therapeutics | -$3.38 | — | -$0.69 | — | — | — | $6.00K | — | 08/12/2020 | Get Alert |
| BEAM | Beam Therapeutics | — | -$0.52 | -$1.03 | -98.08% | — | — | $6.00K | — | 05/12/2020 | Get Alert |
Beam Therapeutics (BEAM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-25 | $-1.09 | $-1.28 | 14.8 % |
| Q3 | 2024-11-05 | $-1.17 | $-1.16 | -0.86 % |
| Q2 | 2024-08-06 | $-1.11 | $-1.14 | 2.63 % |
| Q1 | 2024-05-07 | $-1.21 | $-1.42 | 14.8 % |
Beam Therapeutics (BEAM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-25 | $30.07M | $15.12M | 98.9 % |
| Q3 | 2024-11-05 | $14.27M | $14.50M | -1.59 % |
| Q2 | 2024-08-06 | $11.77M | $13.73M | -14.3 % |
| Q1 | 2024-05-07 | $7.41M | $16.97M | -56.3 % |
FAQ
When is Beam Therapeutics (NASDAQ:BEAM) reporting earnings?
Beam Therapeutics (BEAM) is scheduled to report earnings on August 5, 2025. The last reported earnings were for reported on February 25, 2025 for Q4.
What were the latest earnings per share (EPS) for Beam Therapeutics (NASDAQ:BEAM)?
The Actual EPS was $-1.09, which beat the estimate of $-1.28.
What were Beam Therapeutics’s (NASDAQ:BEAM) revenues?
The Actual Revenue was $30.1M, which beat the estimate of $15.1M.
Browse earnings estimates, EPS, and revenue on all stocks.
